Keating Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $356K | Hold |
6,182
| – | – | 0.1% | 46 |
|
|
2026
Q1 | $375K | Sell |
6,182
-655
| -10% | -$38.2K | 0.09% | 46 |
|
|
2025
Q4 | $369K | Sell |
6,837
-20
| -0.3% | -$962 | 0.1% | 50 |
|
|
2025
Q3 | $309K | Sell |
6,857
-1,560
| -19% | -$72.9K | 0.09% | 55 |
|
|
2025
Q2 | $390K | Sell |
8,417
-3,000
| -26% | -$147K | 0.12% | 50 |
|
|
2025
Q1 | $696K | Hold |
11,417
| – | – | 0.21% | 45 |
|
|
2024
Q4 | $646K | Buy |
11,417
+2,660
| +30% | +$149K | 0.2% | 44 |
|
|
2024
Q3 | $453K | Sell |
8,757
-1,600
| -15% | -$75.1K | 0.14% | 49 |
|
|
2024
Q2 | $430K | Sell |
10,357
-1,255
| -11% | -$56.2K | 0.14% | 51 |
|
|
2024
Q1 | $630K | Sell |
11,612
-8,425
| -42% | -$429K | 0.2% | 50 |
|
|
2023
Q4 | $1.03M | Sell |
20,037
-100
| -0.5% | -$5.25K | 0.37% | 51 |
|
|
2023
Q3 | $1.17M | Hold |
20,137
| – | – | 0.4% | 39 |
|
|
2023
Q2 | $1.29M | Sell |
20,137
-1,300
| -6% | -$87.2K | 0.47% | 38 |
|
|
2023
Q1 | $1.49M | Buy |
21,437
+100
| +0.5% | +$7.05K | 0.56% | 36 |
|
|
2022
Q4 | $1.54M | Buy |
21,337
+1,700
| +9% | +$128K | 0.6% | 36 |
|
|
2022
Q3 | $1.4M | Sell |
19,637
-50
| -0.3% | -$3.63K | 0.63% | 33 |
|
|
2022
Q2 | $1.52M | Sell |
19,687
-150
| -0.8% | -$11.4K | 0.64% | 33 |
|
|
2022
Q1 | $1.45M | Sell |
19,837
-100
| -0.5% | -$6.71K | 0.62% | 38 |
|
|
2021
Q4 | $1.24M | Hold |
19,937
| – | – | 0.55% | 39 |
|
|
2021
Q3 | $1.18M | Sell |
19,937
-100
| -0.5% | -$6.59K | 0.55% | 37 |
|
|
2021
Q2 | $1.34M | Hold |
20,037
| – | – | 0.61% | 36 |
|
|
2021
Q1 | $1.26M | Sell |
20,037
-1,975
| -9% | -$123K | 0.61% | 34 |
|
|
2020
Q4 | $1.36M | Hold |
22,012
| – | – | 0.68% | 33 |
|
|
2020
Q3 | $1.33M | Sell |
22,012
-200
| -0.9% | -$12K | 0.69% | 32 |
|
|
2020
Q2 | $1.31M | Hold |
22,212
| – | – | 0.72% | 30 |
|
|
2020
Q1 | $1.24M | Hold |
22,212
| – | – | 0.76% | 30 |
|
|
2019
Q4 | $1.43M | Sell |
22,212
-60
| -0.3% | -$3.44K | 0.62% | 38 |
|
|
2019
Q3 | $1.13M | Sell |
22,272
-2,050
| -8% | -$96.3K | 0.51% | 40 |
|
|
2019
Q2 | $1.1M | Hold |
24,322
| – | – | 0.49% | 43 |
|
|
2019
Q1 | $1.16M | Sell |
24,322
-600
| -2% | -$29.9K | 0.52% | 43 |
|
|
2018
Q4 | $1.29M | Hold |
24,922
| – | – | 0.66% | 38 |
|
|
2018
Q3 | $1.55M | Sell |
24,922
-1,300
| -5% | -$77.1K | 0.67% | 38 |
|
|
2018
Q2 | $1.45M | Sell |
26,222
-300
| -1% | -$16.2K | 0.69% | 37 |
|
|
2018
Q1 | $1.68M | Sell |
26,522
-3,360
| -11% | -$216K | 0.77% | 37 |
|
|
2017
Q4 | $1.83M | Hold |
29,882
| – | – | 0.78% | 37 |
|
|
2017
Q3 | $1.91M | Sell |
29,882
-200
| -0.7% | -$11.7K | 0.83% | 37 |
|
|
2017
Q2 | $1.68M | Hold |
30,082
| – | – | 0.73% | 38 |
|
|
2017
Q1 | $1.64M | Sell |
30,082
-8,100
| -21% | -$444K | 0.73% | 36 |
|
|
2016
Q4 | $2.23M | Sell |
38,182
-175
| -0.5% | -$9.57K | 1.05% | 33 |
|
|
2016
Q3 | $2.07M | Sell |
38,357
-1,690
| -4% | -$109K | 1.01% | 32 |
|
|
2016
Q2 | $2.94M | Sell |
40,047
-7,057
| -15% | -$499K | 1.44% | 29 |
|
|
2016
Q1 | $3.01M | Sell |
47,104
-44,012
| -48% | -$2.78M | 1.47% | 29 |
|
|
2015
Q4 | $6.27M | Sell |
91,116
-895
| -1% | -$59.1K | 3.14% | 11 |
|
|
2015
Q3 | $5.45M | Sell |
92,011
-890
| -1% | -$56.5K | 2.93% | 13 |
|
|
2015
Q2 | $6.18M | Sell |
92,901
-1,535
| -2% | -$101K | 3.15% | 11 |
|
|
2015
Q1 | $6.09M | Sell |
94,436
-1,800
| -2% | -$113K | 3.05% | 11 |
|
|
2014
Q4 | $5.68M | Sell |
96,236
-290
| -0.3% | -$16.4K | 2.83% | 13 |
|
|
2014
Q3 | $4.94M | Sell |
96,526
-3,708
| -4% | -$185K | 2.55% | 20 |
|
|
2014
Q2 | $4.86M | Sell |
100,234
-1,250
| -1% | -$61.6K | 2.34% | 23 |
|
|
2014
Q1 | $5.27M | Sell |
101,484
-9,193
| -8% | -$489K | 2.63% | 17 |
|
|
2013
Q4 | $5.88M | Sell |
110,677
-8,450
| -7% | -$430K | 3% | 15 |
|
|
2013
Q3 | $5.51M | Sell |
119,127
-3,475
| -3% | -$153K | 3.07% | 15 |
|
|
2013
Q2 | $5.48M | Buy |
+122,602
| New | +$5.32M | 3.09% | 14 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Keating Investment Counselors's BMY Position: Q2 2026 in Review
Keating Investment Counselors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,182 shares worth $356K. The position accounts for 0.1% of the portfolio, ranked #46.
Keating Investment Counselors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.27M in Q4 2015. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Keating Investment Counselors held 6,182 shares of Bristol-Myers Squibb worth $356K as of Q2 2026.
- Keating Investment Counselors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.1% of Keating Investment Counselors's portfolio in Q2 2026, its #46 holding.
- Keating Investment Counselors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Keating Investment Counselors's Bristol-Myers Squibb position peaked at $6.27M in Q4 2015.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.